SCHEMBL30936655

SCHEMBL30936655

CC1CCC(Nc2ccccc2[N+](=O)[O-])CC1

nearest known ligand 0.58

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 6/20 0.58
HCAR3 P49019 3/20 0.51
MAPT P10636 7/20 0.48
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
ACHE P22303 1/20 0.47
ALDH1A1 P00352 6/20 0.46
L3MBTL1 Q9Y468 4/20 0.46
TDP1 Q9NUW8 3/20 0.46
CASP7 P55210 1/20 0.46
GAA P10253 3/20 0.46
GLA P06280 1/20 0.46
CYP1A2 P05177 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
HTT P42858 1/20 0.45
LMNA P02545 2/20 0.45
PKM P14618 1/20 0.43
RAB9A P51151 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL718625 0.92 MAPK1 (0.65) MAPK1HCAR3MAPTMEN1KMT2A
SCHEMBL30936592 0.85 MAPK1 (0.62) MAPK1HCAR3MAPTMEN1KMT2A
SCHEMBL2930805 0.85 MAPK1 (0.62) MAPK1HCAR3MAPTMEN1KMT2A
SCHEMBL4077406 0.85 MAPK1 (0.62) MAPK1HCAR3MAPTMEN1KMT2A
SCHEMBL8724028 0.84 MAPK1 (0.61) MAPK1HCAR3MAPTMEN1KMT2A
SCHEMBL29065575 0.84 MAPK1 (0.58) MAPK1HCAR3MAPTMEN1KMT2A
SCHEMBL22725465 0.84 MAPK1 (0.58) MAPK1HCAR3MAPTMEN1KMT2A
SCHEMBL22725450 0.84 MAPK1 (0.58) MAPK1HCAR3MAPTMEN1KMT2A
SCHEMBL541921 0.84 KMT2A (0.64) MAPK1HCAR3MAPTMEN1KMT2A
SCHEMBL30536224 0.84 MAPK1 (0.54) MAPK1HCAR3MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250340510-A1 Substituted Phenylbenzenesulfonamide Derivatives and Uses Thereof NINE SQUARE THERAPEUTICS CORPORATION (US) 2025-11-06 US disclosed
EP-4608389-A2 SUBSTITUTED PHENYLBENZENESULFONAMIDE DERIVATIVES AND USES THEREOF Nine Square Therapeutics Corporation (US) 2025-09-03 EP disclosed
WO-2024092235-A2 SUBSTITUTED PHENYLBENZENESULFONAMIDE DERIVATIVES AND USES THEREOF NINE SQUARE THERAPEUTICS CORPORATION (US) 2024-05-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250340510-A1 Substituted Phenylbenzenesulfonamide Derivatives and Uses Thereof TRPM2, TRPM6, TRPM5 MAPK1 1601/4885HCAR3 1268/4885MAPT 39/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.